Hepatitis D screening

Hepatitis Main Page
Hepatitis D
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Hepatitis D from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Hepatitis D screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatitis D screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatitis D screening
CDC on Hepatitis D screening
Hepatitis D screening in the news
Blogs on Hepatitis D screening
Directions to Hospitals Treating Hepatitis D
Risk calculators and risk factors for Hepatitis D screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]

Screening

All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients. The following preventive and screening may be applied in:

• HBsAg positive patients, who have acute or chronic hepatitis D. The follow-up procedures should be equal, regardless of co-infection status with hepatitis D
• Patients who have acute hepatitis B, are not HBsAg positive yet and who are IgM anti-HBc positive may be tested for HDV.